Abstract
We previously reported that a treatment of cultures of endothelial cells from bovine aorta with thrombin resulted in a less accumulation of glycosaminoglycans (GAG) in the cell layer. In the present study, we found that thrombin-induced decrease in the accumulation of [35s]sulfate-labeled GAG (35S-GAG) such as heparan sulfate was prevented by antithrombin III (AT III) but not by heparin cofactor II (HC II). However, AT III did not show a significant effect on the 35S-GAG accumulation individually. Pretreatment of the cell layer with neither AT III not HC II showed any preventive effect. When GAG in the cell layer was labeled with both [35s]sulfate and [35h] glucosamine, neither thrombin nor a combination of thrombin with AT III changed the ratio of the radioactivity of 35S to that of 3H. Although thrombin stimulated the release of 35S-GAG from the cell layer, AT III completely prevented the stimulatory effect. In conclusion, it was suggested that AT III may inhibit the thrombin action on GAG metabolism of endothelial cells to prevent thrombosis in vivo.
Original language | English |
---|---|
Pages (from-to) | 707-716 |
Number of pages | 10 |
Journal | Thrombosis Research |
Volume | 62 |
Issue number | 6 |
DOIs | |
State | Published - 1991/06/15 |
Keywords
- Antithrombin III
- Endothelial cells
- Glycosaminoglycans
- Heparin cofactor II
- Thrombin
- Thrombosis
ASJC Scopus subject areas
- Hematology